Solvent-mediated transformation of a pharmaceutical salt into its monohydrate and free base by Qu, Haiyan et al.
Syddansk Universitet
Solvent-mediated transformation of a pharmaceutical salt into its monohydrate and
free base
Qu, Haiyan; Tian, Fang; Savolainen, Marja Riikka; Christensen, Lars Porskjær ; Rantanen,
Jukka
Published in:
19<sup>th</sup> International Congress of Chemical and Process Engineering (CHISA 2010) and the 7<sup>th
</sup>European Congress of Chemical Engineering (ECCE-7)
Publication date:
2010
Document version
Final published version
Citation for pulished version (APA):
Qu, H., Tian, F., Savolainen, M. R., Christensen, L. P., & Rantanen, J. (2010). Solvent-mediated transformation
of a pharmaceutical salt into its monohydrate and free base. In 19th International Congress of Chemical and
Process Engineering (CHISA 2010) and the 7th European Congress of Chemical Engineering (ECCE-7) (pp.
1929-1930). [P1.242 (serial number 0682)]
General rights
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners
and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights.
            • Users may download and print one copy of any publication from the public portal for the purpose of private study or research.
            • You may not further distribute the material or use it for any profit-making activity or commercial gain
            • You may freely distribute the URL identifying the publication in the public portal ?
Take down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Download date: 19. Apr. 2017
Solvent-mediated transformation of a pharmaceutical salt into its 
monohydrate and free base
H  . Qu  1,2, F. Tian1, M. Savolainen1, L. P. Christensen2, J. Rantanen1
1Department of Pharmaceutics and Analytical Chemistry, Faculty of Pharmaceutical 
Sciences, University of Copenhagen, Universitetsparken 2, 2100 Copenhagen, Denmark. 
2 Institute of Chemical Engineering, Biotechnology and Environmental Technology, Faculty 
of Engineering, University of Southern Denmark, Niels Bohrs Allé 1, DK-5230, Odense M, 
Denmark; tel. +4565507494, email: haq@kbm.sdu.dk
The number of poorly-water soluble drug substances is increasing due to increase in the size of 
the new candidate molecules.  One effective way to increase the aqueous solubility of a drug 
substance is salt formation. Nowadays nearly 50% of the drug substances used for therapeutic 
purposes is in salt form. However, the salts may transform into their corresponding free base 
or acid during the processing or storage, especially when water and excipients are presented. 
The  objective  of  the  present  work  is  to  explore  the  underlying  mechanism  of  such 
transformations.
In principle, when the salt is in contact with an aqueous solution with a pH that favors the 
formation of the non-ionic specie,  the transformation of the salt  into its  free base or acid 
might occur. This transformation process consists of the dissolution of the solid salt, transition 
of  the  ionic  species  to  the  non-ionic  species  in  the  solution  phase,  and  the  formation  of 
crystalline or amorphous free base or acid. Furthermore, for the salts which are capable of 
forming hydrates, the transformation from the anhydrate to the hydrate can also be affected by 
the changes of the concentrations of the various ions in the solution. 
Fig. 1 Molecular structure of siramesine hydrochloride (pKa ~ 9).
In the present work, the mechanism of the transformation of a chloride salt, siramesine 
hydrochloride anhydrate (Fig. 1), to its monohydrate and free base was studied by adding 
different amounts of NaOH. When siramesine hydrochloride (SMHCl) is dissolved in water, 
the solid-liquid equilibrium between SMHCl (solid) and (SMH+ + Cl-)  (solution),  and the 
reaction equilibrium between SM and SMH+ in solution are attained (shown by the black 
colored scheme in Fig. 2). It has been observed that the concentration of SMH+ approached to 
its saturate concentration at 256 µg/mL within 40 min.  Although the solubility of SMHCl 
monohydrate in water is only 6.1 µg/mL, the phase transformation from the anhydrate to the 
monohydrate did not happen after keeping the anhydrate in suspension for three days. It has 
also been observed that the solubility of the salt is determined by its solubility product Ksp:
−+= ClSMHsp mmK    Where m is the concentration of the ions in molal unit.
When NaOH is  added to  the  solution,  the  concentration  of  H+ is  decreased,  and the 
reaction equilibrium shifts to the right, resulting in transformation of the SMH+ to the free 
base SM. The shifting of the reaction equilibrium consequently leads to the dissolution of the 
SMHCl solid, which then leads to the accumulation of Cl- in the solution. Since the solubility 
product of the anhydrate salt  Ksp keeps constant, the increased concentration of Cl-  results in 
decreased equilibrium concentration of SMH+ in the solution. This has been confirmed in the 
experiments where the concentration of siramesine in solution rapidly decreased from 256 µg/
mL to < 2 µg/mL and remained at a very low level for over three days. The shifting of the 
reaction equilibrium also leads to an increased concentration of SM in solution, which might 
drive out the crystallization of the free base as shown by the white colored arrow in Fig. 2.
                    ++ +++ HCl SMClSMH --  
Fig. 2 Scheme of the solid-liquid and reaction equilibriums developed in an aqueous solution 
of siramesine hydrochloride salt.
Table  1  Phase  transformation  of  the  anhydrate  and  monohydrate  of  siramesine 
hydrochloride in aqueous suspensions with different amounts of NaOH.  
                  Time (hour)
Molar ratio         
NaOH:SMHCl
0 24 48 72
0:1 A M A 
(4.8)
M 
(5.7)
A 
(4.8)
M A 
(4.8)
M
1:4 A M A 
(5.7)
M+B 
(6.8)
A 
(5.6)
M+B 
(6.6)
A 
(5.5)
M+B 
(6.5)
1:2 A M A+B 
(5.5)
M+B 
(6.9)
B+M 
(5.4)
M+B 
(6.8) 
B+M 
(5.6)
M+B 
(6.7)
1:1 A M A+B 
(11.3)
M+B 
(9.3)
B 
(8.8)
B 
(6.8)
B 
(7.9)
B 
(6.8)
(A=anhydrate salt; M=monohydrate; B=free base; pH of the suspension are shown inside the 
brackets; the grey background denotes the starting material was SMHCl monohydrate.)
Different amounts of NaOH were added to the solution to obtain different molar ratios of 
the anhydrate salt and NaOH. The phase transformation results are summarized in Table 1. 
When the molar ratio of NaOH to SMHCl was 1:4, the anhydrate salt did not transform to 
either  the monohydrate  or the free base.  However,  when the same amount  of NaOH was 
added  to  the  monohydrate  SMHCl suspension,  the  phase  transformation  to  the  free  base 
started  within  3.5  hours.  This  probably  suggested  that  the  presence  of  the  SMHCl 
monohydrate can promote the crystallization of the free base. Another interesting observation 
from Table 1 is that when the mole ratio of NaOH to SMHCl was 1:2, the anhydrate SMHCl 
partly transformed to the free base after 24 hours, and then the solid phase became to be a 
mixture of the monohydrate and the free base after 48 hours. This observation implied that the 
free base can also act as a catalyst for the crystallization of the monohydrate. When the molar 
ratio  of  NaOH to  SMHCl  was  1:1,  the  pH change  of  the  suspension  suggested  that  the 
equilibriums shown in Fig. 2 were developed again within 48 hours for the monohydrate. This 
also supports the conclusion that the transformation rate of monohydrate SMHCl to the base 
is faster than that of the anhydrate SMHCl to the base.
The obtained knowledge is useful for the understanding of the phase transformation of 
siramesine hydrochloride salt, and hence for controlling the salts transformation during drug 
processing. 
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